News


All News

Anew option is available to all physicians, whether they seek healthcare insurance coverage for themselves and their families or affordable options for the employees of their practice.

New York - As injectable filler options grow, so do their power to offer patients a second round of youthful looks. The market is expanding with fillers that offer various compositions, indications, durations of effect, and stages of FDA approval. The growing choices are cause for celebration and consideration.

New York - Imagine fat as a substance bundled into intact parcels that are a size and shape allowing for them to travel through a small cannula - both when harvested and injected. This is the key to transferring the permanent subcutaneous filler, Sydney R. Coleman, M.D. said.

Aging healthfully

New York - A comprehensive, science-based health assessment designed to detect risk factors for age-related diseases is one tool for narrowing the gap between health expectancy and life expectancy, said Gary Bucher, M.D., medical director, Kronos Optimal Health Co., Phoenix.

Washington D.C. -- Scalp biopsies are a very useful aid in the evaluation of hair loss if they are done and interpreted correctly, said Leonard C. Sperling, M.D., at the annual meeting of the American Academy of Dermatology.

San Diego - Much of the aging process is about gravity trying to pull us out through the soles of our feet, and eventually it succeeds, said Michael Colgan, Ph.D. A physiologist and biochemist, Colgan called humans "the most domesticated animal" and said that our sedentary habits exacerbate the impact of gravity.

Deer Valley, Utah -- Patients seeking long-lasting cosmetic improvement without a facelift have a new treatment modality - non-ablative radiofrequency (RF) - in which improvement continues for up to six months after a single treatment.

Washington - Extensive skin cancer can be a life-ruining or even lethal event for organ transplant recipients. Speaking at the annual meeting of the American Academy of Dermatology, Clark C. Otley, M.D., reviewed for his colleagues five lessons he learned, some times the hard way, to address this challenging problem.

Pediatric purpura

Miami, Fla. - Pediatric dermatologists and pediatricians often see children with purpura, which presents cutaneously but can be a sign of systemic abnormalities.

Washington -- New therapies continue to emerge in pediatric dermatology, and recent studies demonstrate the effectiveness of such therapies. Ilona J. Frieden, M.D., highlighted studies in some areas of common concern in a presentation at the annual meeting of the American Academy of Dermatology.

Washington - Timely diagnosis of juvenile dermatomyositis is critical, because early aggressive management with immunosuppressive agents - even for patients with amyopathic disease - is the best method for preventing calcinosis that is a source of significant morbidity for these children, said Amy S. Paller, M.D., at the annual meeting of the American Academy of Dermatology.

Boston -- Skin lesions often provide significant clues for diagnosing infections seen among international travelers. A new review of dermatologic infectious diseases in international travelers describes some of the more common conditions, and looks at changes in treatment.

Washington D.C. -- Testing conducted at the Dermatology Center at the University of Manchester's (U.K.) Hope Hospital shows magnetic resonance (MR) scanning can help dermatologists get a better subcutaneous look at patients' port wine stains. However, it fell short of providing the predictability doctors desired with respect to estimating how patients would respond to pulsed dye laser (PDL) treatments.

Washington - According to a poster study presented at the annual American Academy of Dermatology meeting, oral tazarotene (Tazorac; Allergan Inc., Irvine, Calif.) gives patients with plaque psoriasis significant improvements that continue after treatment stops. The blinded, placebo-controlled multicenter study of approximately 700 patients shows that oral tazarotene delivers several advantages over existing alternatives for treating plaque psoriasis.

Washington - Topical application of anti-tumor necrosis factor-? (TNF-?) monoclonal antibody (infliximab) produced dramatic improvement with wound closure in chronic, non-healing leg ulcers, said Markus Streit, M.D., department of dermatology, Inselspital, Bern, Switzerland.

Washington - Biological treatments for psoriasis have largely unraveled the once-secret mechanisms behind this disease. "The biologics including Amevive [alefacept], Raptiva [efalizumab], Embrel [etanercept], and Remicade [infliximab] are scientifically revolutionary and exciting," said John Y. M. Koo, M.D., who spoke about these treatments at the American Academy of Dermatology meeting. Board-certified in dermatology and psychiatry, he is professor and vice chairman of the University of California at San Francisco's department of dermatology.

Washington - The recently concluded American Academy of Dermatology conference witnessed the first published report documenting the safety and efficacy of the Smoothbeam laser treatment for inflammatory facial acne. Building on previous research that showed the 1,450-nm diode laser to be effective for treating inflammatory acne on the back, a team of researchers led by Paul M. Friedman, M.D., showed the same type of laser to be safe and effective for treating facial acne vulgaris.

Dosing strategies

Washington - The optimum doses of biologic treatments for psoriasis may be higher than previously believed, according to Mark Lebwohl, M.D., professor and chairman, department of dermatology, Mt. Sinai School of Medicine.

Dr. Smarts wants to start performing clinical research studies in his office. He assumes that such research will bring him the press notoriety that will boost his lagging dermatology practice. Dr. Smarts begins to evaluate a new substance for the treatment of psoriasis not approved by the FDA. He verbally tells his patients they are research "guinea pigs"; he lets them know he is able to obtain the as-of-now unobtainable material from a local compounding pharmacy.

About 15 years ago, while riding on a shuttle bus at the annual American Academy of Dermatology meeting, I overheard two elderly dermatologists discussing the state of dermatology, as they perceived it. One gentleman commented that he had not seen a single advance to rival the advent of tetracycline for acne, and that most of the new treatments did not work very well. At the time, I remember thinking that these practitioners were out of touch with all of the hot new therapies for skin disorders. Since that time, as I have been bombarded by myriad new and supposedly revolutionary "advances," I, too, am beginning to question whether we should equate the concept of "newness"

Maui, Hawaii - Most research on the power of intercessory prayer indicates that it has no affect on healing. But there have been some studies suggesting otherwise; many of these were later vivisected on methodological grounds.

Fair or foul play?

None of us likes to do it, but every practitioner must eventually face up to the unpleasant task of terminating an employee. "Firing people is one of the toughest, most unpleasant things you do as an employer," says James Walsh in his book, "Rightful Termination."

Wailea, Hawaii - An oral nutritional supplement can resolve both cellulite and striae on the thighs and abdomen and improve skin firmness, according to Howard Murad, M.D., who spoke here at the Noah Worcester Dermatological Society meeting. In a double-blind, randomized, placebo-controlled trial, he and other researchers found that this supplement produced superior results over placebo. The supplement consisted of a combination of amino acids, B-vitamins, essential fatty acids and trace minerals.

Masters of pediatrics

Welcome to a new department in Dermatology Times. Beginning with this month's Special Report, DT will present a monthly panel review of specific cases in pediatric dermatology, an effort coordinated by editorial adviser Lawrence Schachner, M.D. In this installment, a panel of pediatric masters discusses treatment options for the unusual case of a 12-year-old Hispanic girl who was brought in by her parents for treatment of a white spot that had developed after she was out playing in the sun.